ACARFIX-25

Composition: Acarbose 25mg

Indication:
A convenient and effective long-term option for the treatment of Type 2 Diabetes

ACARFIX-50

Composition: Acarbose 50mg

Indication:
A convenient and effective long-term option for the treatment of Type 2 Diabetes

DAPASUG-10

Composition: Dapagliflozin 10mg

Indication:
Type 2 Diabetes

DAPASUG-5

Composition: Dapagliflozin 5mg

Indication:
Type 2 Diabetes

DAPASUG-GM-2 Tablet

Composition: Dapagliflozin 10mg + Glimepiride IP 2mg + Metformin Hydrochloride IP 1000mg (As extended release form)

Indication:
Patients with T2D with eCVD or multiple CV risk factors, to reduce the risk of hospitalization for heart failure

DAPASUG-M

Composition: Dapagliflozin 10mg + Metformin 500mg ER

Indication:
Patients with heart failure with reduced ejection fraction, to reduce the risk of CV death and hospitalization for heart failure, Patients with T2D with eCVD or multiple CV risk factors, to reduce the risk of hospitalization for heart failure

DAPASUG-SM-500

Composition: Dapagliflozin 10mg + Sitagliptin 100mg + Metformin (ER) 500mg

Indication:
Treatment of Type 2 Diabetes mellitus

DAPASUG-ST-100

Composition: Sitagliptin Phosphate Monohydrate 100mg + Dapagliflozin Propanediol Monohydrate 10mg

Indication:
A highly potent, reversible and selective sodium-glucose contransporter-2 inhibitor indicated worldwide for the treatment of Type 2 diabetes

DAPASUG-TG 20

Composition: Dapagliflozin 10mg + Teneligliptin 20mg

Indication:
Ensure Victory in controlling Diabetes

DAPASUG-VD 5/50 TABS

Composition: Dapagliflozin 5mg + Vildagliptin 50mg

Indication:
TYPE 2 DIABETES

DAPASUG-VD 50 (COMING SOON)

Composition: Dapagliflozin 10mg + Vildagliptin 50mg

Indication:
Diffuse the load of Diabetes before it Blast

DAPASUG-VD-100

Composition: Dapagliflozin 10mg & Vildagliptin 100mg (Bilayered in Sustained Release Tablet)

Indication:
TYPE 2 DIABETES

LINASUG-5

Composition: Composition: Linagliptin 5 mg

Indication:
used along with diet and exercise and sometimes with other medications to lower blood sugar levels in patients with type 2 diabetes

LINASUG-DM 500

Composition: Lingaliptin 5mg+Dapagliflozin 10mg+ Metformin Hcl (SR) 500mg/1000mg

Indication:
Reduces the hepatic glucose uptake by 19%.

LINASUG-DP Tablet

Composition: Linagliptin 5mg + Dapagliflozin 10mg

Indication:
Used medications for the treatment of type-2 diabetes mellitus (T2DM)

LINASUG-M 2.5/500

Composition: Linagliptin 2.5 mg, Metformin Hydrochloride IP 500 mg

Indication:
used along with diet and exercise and sometimes with other medications to lower blood sugar levels in patients with type 2 diabetes

LINASUG-M 5/500 Tab

Composition: Linagliptin 5 mg and Metformin Hydrochloride (SR) 500 mg Tablets

Indication:
Indicated as an adjunct to diet & exercise to improve glycemic Control in Adults with Type 2 Diabetes Mellitus

NITOFRESH ADVANCE MOUTH WASH

Composition: Chlorhexidine Gluconate 0.2% w/v, Sodium Fluoride 0.05% w/v, Zinc 0.09% w/v & Hyaluronic acid 0.1%

Indication:
Halitosis and Gingivitis, Maintenance of Oral Hygiene, Dental caries, Dental Scaling and Sponging & Periodontitis

SITANOW-100

Composition: Sitagliptin 100mg

Indication:
As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

SITANOW-50

Composition: Sitagliptin 50mg

Indication:
As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

SITANOW-M 1000

Composition: Sitagliptin 50mg + Metformin Hydrochloride IP 1000mg

Indication:
As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

SITANOW-M 500

Composition: Sitagliptin 50mg + Metformin Hydrochloride IP 500mg

Indication:
As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

SUGALIFE-40

Composition: Gliclazide 40mg

Indication:
Obese Type 2 Diabets , Secondary falure with su/Metformin, Moderate fo severe NIDDm, NiDDm with vascular complications.

SUGALIFE-80

Composition: Gliclazide 80mg

Indication:
Obese Type 2 Diabets , Secondary falure with su/Metformin, Moderate fo severe NIDDm, NiDDm with vascular complications.

SUGALIFE-M

Composition: Gliclazide 80mg + Metformin 500mg

Indication:
Obese Type 2 Diabets , Secondary falure with su/Metformin, Moderate fo severe NIDDm, NiDDm with vascular complications.

SUGAMIDE-1

Composition: Glimepiride 1mg

Indication:
"Metformin and glimepiride simultaneously targets insulin resistance and insulin deficiency in type 2 diabetes"

SUGAMIDE-2

Composition: Glimepiride 2mg

Indication:
"Metformin and glimepiride simultaneously targets insulin resistance and insulin deficiency in type 2 diabetes"

SUGAMIDE-M-1

Composition: Glimepiride 1mg + Metformin 500mg (Bi Layer Tablet) (In SR)

Indication:
Metformin and glimepiride simultaneously targets insulin resistance and insulin deficiency in type 2 diabetes

SUGAMIDE-M-2 NANO FAST Tabs

Composition: Glimepiride 2mg + Metformin 500mg (In SR)

Indication:
Complete Control over Uncontrolled Diabetes, IMICKRO Nano Technology gives Immediate and Patterned Release (IPR) drug profile

SUGAMIDE-M1 1000

Composition: Glimepiride 1mg + metformin 1000mg in SR,

Indication:
"Metformin and glimepiride simultaneously targets insulin resistance and insulin deficiency in type 2 diabetes"

SUGAMIDE-M2

Composition: Glimepiride 2mg + Metformin 500mg (In SR)

Indication:
Metformin and glimepiride simultaneously targets insulin resistance and insulin deficiency in type 2 diabetes

SUGAMIDE-M2 1000

Composition: Combination – Glimepiride 2mg + metformin 2000mg,

Indication:
"Metformin and glimepiride simultaneously targets insulin resistance and insulin deficiency in type 2 diabetes"

SUGAMIDE-M3 FORTE

Composition: Glimepiride 3mg + Metformin 1000mg

Indication:
Type 2 Diabetes

SUGAMIDE-M4 FORTE

Composition: Glimepiride 4mg + Metformin 1000mg

Indication:
Type 2 Diabetes

SUGAMIDE-PM-1

Composition: Glimepiride 1mg + Pioglitazone 15mg + Metformin 500mg (In SR)

Indication:
Type 2 Diabetes

SUGAMIDE-PM-2

Composition: Glimepiride 2mg +Pioglitazone 15mg + Metformin 500mg (In SR)

Indication:
Type 2 Diabetes

SUGAMIDE-PM-2 NANO FAST Tabs

Composition: Glimepiride 2mg + Pioglitazone 15mg + Metformin 500mg (In SR)

Indication:
Complete Control over Uncontrolled Diabetes, IMICKRO Nano Technology gives Immediate and Patterned Release (IPR) drug profil

SUGAPILL-50

Composition: Vildagliptin 50mg

Indication:
Type-2 Diabetes

SUGAPILL-M 1000

Composition: Vildagliptin 50mg + Metformin 1000mg Film Coated

Indication:
Type-2 Diabetes

SUGAPILL-M 500

Composition: Vildagliptin 50mg + Metformin 500mg Film Coated

Indication:
Type-2 Diabetes..

SUGAPILL-M 850

Composition: Vildagliptin 50mg + Metformin 850mg Film Coated

Indication:
Type-2 Diabetes

SUGAPILL-PIO

Composition: Vildagliptin 50mg + Pioglitazone HCI 15mg

Indication:
Type 2 Diabetes

SUGAVIA-100

Composition: Sitagliptin 100mg

Indication:
As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

SUGAVIA-50

Composition: Sitagliptin 50mg

Indication:
As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

SUGAVIA-M 500

Composition: Sitagliptin 50mg + Metformin Hydrochloride IP 500mg

Indication:
As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

TENIFIX-20

Composition: Teneligliptin 20mg

Indication:
As a monotherapy adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus (T2DM).

TENISUG-20

Composition: Teneligliptin 20mg

Indication:
Stage 2 Hypertension, Hypertension associated with diabetes.

TENISUG-M 1000

Composition: Teneligliptin 20mg + Metformin Hydrochloride 1000mg (Prolonged Release)

Indication:
Stage 2 Hypertension, Hypertension associated with diabetes.

TENISUG-M 500

Composition: Teneligliptin 20mg + Metformin Hydrochloride 500mg (Prolonged Release)

Indication:
Stage 2 Hypertension, Hypertension associated with diabetes.

TENISUG-PG

Composition: Teneligliptin 20mg + Pioglitazone 15 mg

Indication:
For adults with Uncontrolled Type 2 Diabetes.

TENISUG-PM TABS

Composition: Teneligliptin 20mg +Pioglitazone 15mg + Metformin 500 MG (ER)

Indication:
Used for the treatment of type 2 diabetes

VIAMETA-1000 SR

Composition: Metformin Hydrochloride 1000mg (SR Form)

Indication:
Obese patients where it normalizes body weight and blood sugar level, • Monotherapy for Adults with Type-II diabetes where diet, weight reduction and exercise have failed to control blood sugar level

VIAMETA-500 SR

Composition: Metformin Hydrochloride 500 (SR Form)

Indication:
Obese patients where it normalizes body weight and blood sugar level, • Monotherapy for Adults with Type-II diabetes where diet, weight reduction and exercise have failed to control blood sugar level

VOGLISUG-0.2

Composition: Voglibose 0.2mg (Mouth Dissolving)

Indication:
Lowers post-prandial blood glucose levels in type II diabetics, Prevents sudden surge of glucose after meals, Reduces progression of IGT* to Diabetes.

VOGLISUG-0.3

Composition: Voglibose 0.3mg (Mouth Dissolving)

Indication:
Lowers post-prandial blood glucose levels in type II diabetics, Prevents sudden surge of glucose after meals, Reduces progression of IGT* to Diabetes.

VOGLISUG-GM

Composition: Voglibose 0.2mg + Glimepiride 2mg + Metformin HCL 500mg

Indication:
Lowers post-prandial blood glucose levels in type II diabetics, Prevents sudden surge of glucose after meals, Reduces progression of IGT* to Diabetes.

VOGLISUG-GM 3

Composition: Voglibose 0.3mg + Glimepiride 2mg+ Metformin HCI 500mg

Indication:
Lowers post-prandial blood glucose levels in type II diabetics, Prevents sudden surge of glucose after meals, Reduces progression of IGT* to Diabetes.

VOGLISUG-RAPID TAB

Composition: Repaglinide 1mg + Voglibose 0.3mg

Indication:
Helps control blood sugar levels by stimulating insulin release and slowing carbohydrate absorption, thereby reducing post-meal blood glucose spikes.

VOGLISUG-TRIO 0.2 TABS

Composition: Voglibose IP 0.2mg + Gliclazide IP 80mg + Metformin Hydrochloride IP 500mg

Indication:
Moderate to severe Type II Diabetes, Type II diabetes not adequately controlled by monotherapy

VOGLISUG-TRIO 0.3 Tablets

Composition: Gliclazide 80mg + Metformin Hcl. 500mg + Voglibose 0.3mg

Indication:
Gliclazide 80mg + Metformin Hcl. 500mg + Voglibose 0.3mg